Johnson & Johnson JNJ has been ordered by a jury to pay $300 million in punitive damages to a woman who blamed her rare asbestos-related cancer on the company’s talc products.
The plaintiff is Donna Olson, who has mesothelioma in her lungs. Bloomberg said Johnson & Johnson faces more than 14,000 claims that its talc powder caused ovarian cancer and mesothelioma, a rare cancer linked to asbestos exposure.
Trials over the cancer claims tied to Johnson & Johnson’s talc-based powders first began in 2016. This New York verdict was the 10th win for talc plaintiffs.
A company spokesperson told Reuters the talc trial had "significant legal and evidentiary errors" which the company believes will warrant reversal amid appeal.
Johnson & Johnson's stock fell sharply following the news, but quickly rebounded. Shares traded around $131.07 at time of publication.
Related Links:
Analysts View Johnson & Johnson's Organic Growth Guidance As Conservative
Johnson & Johnson's Asbestos Woes: Experts Speak Up
Photo credit: Austin Kirk, Flickr
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
